Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature review

Central nervous system (CNS)‐relapsed mantle cell lymphoma (MCL) is a rare, aggressive non‐Hodgkin lymphoma without a standard treatment. Ibrutinib has shown promising results for inducing remission in other non‐Hodgkin lymphomas and may be considered as successful treatment for CNS‐relapsed MCL in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rich, Jessica D., Clark, Stephen M., Fedoriw, Yuri, Jewells, Valerie, Wood, William, Dittus, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787781/
https://www.ncbi.nlm.nih.gov/pubmed/31624617
http://dx.doi.org/10.1002/ccr3.2257
_version_ 1783458353100357632
author Rich, Jessica D.
Clark, Stephen M.
Fedoriw, Yuri
Jewells, Valerie
Wood, William
Dittus, Christopher
author_facet Rich, Jessica D.
Clark, Stephen M.
Fedoriw, Yuri
Jewells, Valerie
Wood, William
Dittus, Christopher
author_sort Rich, Jessica D.
collection PubMed
description Central nervous system (CNS)‐relapsed mantle cell lymphoma (MCL) is a rare, aggressive non‐Hodgkin lymphoma without a standard treatment. Ibrutinib has shown promising results for inducing remission in other non‐Hodgkin lymphomas and may be considered as successful treatment for CNS‐relapsed MCL in the future as well.
format Online
Article
Text
id pubmed-6787781
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67877812019-10-17 Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature review Rich, Jessica D. Clark, Stephen M. Fedoriw, Yuri Jewells, Valerie Wood, William Dittus, Christopher Clin Case Rep Case Reports Central nervous system (CNS)‐relapsed mantle cell lymphoma (MCL) is a rare, aggressive non‐Hodgkin lymphoma without a standard treatment. Ibrutinib has shown promising results for inducing remission in other non‐Hodgkin lymphomas and may be considered as successful treatment for CNS‐relapsed MCL in the future as well. John Wiley and Sons Inc. 2019-09-03 /pmc/articles/PMC6787781/ /pubmed/31624617 http://dx.doi.org/10.1002/ccr3.2257 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Rich, Jessica D.
Clark, Stephen M.
Fedoriw, Yuri
Jewells, Valerie
Wood, William
Dittus, Christopher
Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature review
title Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature review
title_full Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature review
title_fullStr Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature review
title_full_unstemmed Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature review
title_short Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature review
title_sort complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: a case report and literature review
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787781/
https://www.ncbi.nlm.nih.gov/pubmed/31624617
http://dx.doi.org/10.1002/ccr3.2257
work_keys_str_mv AT richjessicad completeremissionwithibrutinibafterallogeneicstemcelltransplantforcentralnervoussystemrelapseofmantlecelllymphomaacasereportandliteraturereview
AT clarkstephenm completeremissionwithibrutinibafterallogeneicstemcelltransplantforcentralnervoussystemrelapseofmantlecelllymphomaacasereportandliteraturereview
AT fedoriwyuri completeremissionwithibrutinibafterallogeneicstemcelltransplantforcentralnervoussystemrelapseofmantlecelllymphomaacasereportandliteraturereview
AT jewellsvalerie completeremissionwithibrutinibafterallogeneicstemcelltransplantforcentralnervoussystemrelapseofmantlecelllymphomaacasereportandliteraturereview
AT woodwilliam completeremissionwithibrutinibafterallogeneicstemcelltransplantforcentralnervoussystemrelapseofmantlecelllymphomaacasereportandliteraturereview
AT dittuschristopher completeremissionwithibrutinibafterallogeneicstemcelltransplantforcentralnervoussystemrelapseofmantlecelllymphomaacasereportandliteraturereview

Ejemplares similares